Measuring the biological effect of presurgical metformin treatment in endometrial cancer

British Journal of Cancer
Vanitha SivalingamEmma Crosbie

Abstract

Preclinical studies in endometrial cancer (EC) show that metformin reduces cellular proliferation by PI3K-AKT-mTOR inhibition. We tested the hypothesis that short-term presurgical metformin reduces cellular proliferation in atypical endometrial hyperplasia (AEH) and endometrioid EC, and assessed the feasibility of using phosphorylated PI3K-AKT-mTOR proteins as tissue end points. Women with AEH or EC received metformin 850 mg twice a day or no drug in the presurgical window between diagnosis and hysterectomy. Before and after the window, tissue samples were obtained; serum markers of insulin resistance (e.g. homeostasis model of assessment of insulin resistance index) were determined; and anthropometrics measured (e.g. BMI). Cell proliferation (Ki-67) and PI3K-AKT-mTOR phosphostatus were assessed by immunohistochemistry and scored blinded to treatment. Twenty-eight metformin-treated and 12 untreated patients, well matched for age and BMI, completed the study. Metformin treatment (median 20 days, range 7-34) was associated with a 17.2% reduction in tumour Ki-67 (95% CI -27.4, -7.0, P=0.002), in a dose-dependent manner. Tumour PI3K-AKT-mTOR protein phosphostatus varied but the effects were not significant after adjusting for chang...Continue Reading

References

Dec 1, 1981·British Journal of Clinical Pharmacology·G T Tucker
Aug 1, 1981·British Journal of Clinical Pharmacology·G T TuckerH F Woods
May 20, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H B SalvesenL A Akslen
Apr 26, 2005·BMJ : British Medical Journal·Josie M M EvansAndrew D Morris
Feb 10, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mitch DowsettRoger A'Hern
Oct 26, 2006·Cancer Research·Mahvash ZakikhaniMichael Pollak
Jan 18, 2007·Journal of the National Cancer Institute·Mitch DowsettUNKNOWN IMPACT Trialists Group
Feb 6, 2010·Breast Cancer Research and Treatment·Mahvash ZakikhaniMichael N Pollak
Oct 30, 2010·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Emma J CrosbieAndrew G Renehan
Jan 19, 2011·Clinical Pharmacokinetics·Garry G GrahamKenneth M Williams
Feb 8, 2011·The Lancet Oncology·Kenneth FearonVickie E Baracos
Feb 18, 2011·American Journal of Obstetrics and Gynecology·Jennifer K BurzawaKaren H Lu
Oct 1, 2011·Journal of the National Cancer Institute·Mitch DowsettUNKNOWN International Ki-67 in Breast Cancer Working Group
Nov 22, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Emma J CrosbieAndrew G Renehan
Nov 30, 2011·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Karuna GargBojana Djordjevic
May 9, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bernardo BonanniAndrea Decensi
Aug 31, 2012·Breast Cancer Research and Treatment·Saroj NiraulaPamela J Goodwin
Mar 5, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Tianbo LiuGe Lou
May 9, 2014·Cell Research·Rosa Bernardi, Luca Gianni
May 28, 2014·Prostate Cancer and Prostatic Diseases·A M JoshuaM Pollak
Oct 2, 2014·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Richard J ZainoLinda R Duska
Oct 22, 2014·Climacteric : the Journal of the International Menopause Society·R WorsleyS R Davis
Dec 3, 2014·American Journal of Obstetrics and Gynecology·Ernst LengyelIris L Romero
Dec 4, 2014·The Lancet Oncology·Melina ArnoldIsabelle Soerjomataram
Mar 6, 2015·Journal of the National Cancer Institute·Pamela J GoodwinVuk Stambolic

❮ Previous
Next ❯

Citations

May 25, 2016·British Journal of Cancer·Patricia SanchoChristopher Heeschen
Oct 4, 2016·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Fatemeh SharifzadehNarges Sheikhansari
Dec 3, 2016·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Sarah KitsonEmma J Crosbie
Dec 13, 2016·Current Opinion in Obstetrics & Gynecology·Yeh C LeeAmit M Oza
Dec 29, 2016·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Akira MitsuhashiMakio Shozu
Nov 29, 2017·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Yan ZhaoDongge Cai
Dec 23, 2017·Biological Chemistry·Stephen SafeKeshav Karki
Oct 28, 2017·The Cochrane Database of Systematic Reviews·Naomi S ClementWilliam Atiomo
Jul 5, 2018·Expert Review of Anticancer Therapy·Elizabeth V Connor, Peter G Rose
Jul 12, 2017·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Mike M NguyenH-H Sherry Chow
Feb 13, 2020·Reproductive Sciences·John Mark P PabonaRosalia Cm Simmen
Mar 25, 2020·American Journal of Clinical Oncology·Jingxiao JinMichelle S Ludwig
Apr 6, 2018·International Journal of Oncology·Guiju TangZehua Wang
Dec 3, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Benjamin D HopkinsLewis C Cantley
Apr 27, 2017·Current Urology Reports·Jessica WhitburnPrasanna Sooriakumaran
Aug 5, 2017·Diabetologia·Brandy M Heckman-StoddardLeslie G Ford
Sep 23, 2018·International Journal of Molecular Sciences·Hans-Juergen Schulten
Dec 15, 2019·Journal of Clinical Medicine·Eugeni Lopez-BonetJavier A Menendez
Feb 6, 2020·The Journal of Obstetrics and Gynaecology Research·Akira Mitsuhashi, Makio Shozu
Oct 6, 2018·International Journal of Cancer. Journal International Du Cancer·Michelle L MacKintoshEmma J Crosbie
Nov 15, 2018·Current Oncology Reports·Michelle L MacKintosh, Emma J Crosbie
Jan 3, 2020·International Journal of Molecular Medicine·Miao GuoWei Huang
Sep 14, 2018·Frontiers in Oncology·Teresa Y LeeJennifer M Johnson
Dec 11, 2019·British Journal of Cancer·Vanitha N SivalingamEmma J Crosbie
Jun 20, 2019·Frontiers in Oncology·Sarah J KitsonEmma J Crosbie
Aug 28, 2020·International Journal of Molecular Sciences·Satoru Kyo, Kentaro Nakayama
Nov 23, 2016·Cancer Discovery·Claudio VernieriValter Longo
Dec 20, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sarah J KitsonEmma J Crosbie
Oct 16, 2020·Biochimica Et Biophysica Acta. Reviews on Cancer·Bahar Yetkin-ArikCornelis J F van Noorden
Apr 30, 2021·British Journal of Cancer·Maria M RubinsteinNeil M Iyengar
Apr 19, 2021·Fertility and Sterility·Rohan R ChodankarHilary O D Critchley
Jun 18, 2021·Biomarker Research·Wenyu CaoQing Zhang
Nov 11, 2021·Journal of Drug Targeting·Bartłomiej BarczyńskiJan Kotarski

❮ Previous
Next ❯

Methods Mentioned

BETA
hysterectomy
biopsy
biopsies
ELISA

Clinical Trials Mentioned

ISRCTN81570194

Software Mentioned

Definiens Developer
Definiens

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.